Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
Pathway_ID	Pathway_Name	Self_Enrichment_Rank	Self_Enrichment_Adjusted_P-Value	Min_Adj_P-Value	Max_Adj_P-Value	Avg_Adj_P-Value	Median_Adj_P-Value	Std_Adj_P-Value	Num_total_ranks
hsa05162	Measles	1	1.569131803226259e-58	1.569131803226259e-58	0.8235758770939706	0.09817350589230316	0.0008042085333473999	0.18938241623455862	194
hsa05165	Human papillomavirus infection	1	4.1622747871354985e-73	4.1622747871354985e-73	0.7309012366769446	0.053092326233089696	2.1511958029688e-09	0.12778515372299104	207
hsa05164	Influenza A	1	6.778067489588215e-67	6.778067489588215e-67	0.6921124425837286	0.07676529206288692	0.0001137864093156	0.16421722010321232	194
hsa04613	Neutrophil extracellular trap formation	1	1.2459361341226656e-51	1.2459361341226656e-51	0.956078003416748	0.06499897073658323	1.0359202442362886e-06	0.15624543312395445	211
hsa05163	Human cytomegalovirus infection	1	1.123248396100008e-56	1.123248396100008e-56	0.6923928460623328	0.06188212457373858	7.144874772374615e-06	0.14200228438144868	215
hsa04625	C-type lectin receptor signaling pathway	1	2.148079264234358e-71	2.148079264234358e-71	0.7007148718285032	0.08594054770569806	0.0001657526943403	0.16710190854594623	193
hsa05020	Prion disease	6	1.9072394954293247e-31	2.412782609138398e-56	0.956078003416748	0.06646926199144647	1.2502558398811975e-06	0.14735438055358308	211
hsa05224	Breast cancer	1	6.827967739463837e-69	6.827967739463837e-69	0.7309012366769446	0.08169948025756965	1.0995067734680795e-07	0.17628036653798818	190
hsa04530	Tight junction	1	2.532203128232694e-69	2.532203128232694e-69	0.8760265166196192	0.17796196558175803	0.0516571357331123	0.22411171039370933	190
hsa05225	Hepatocellular carcinoma	2	5.443823426466725e-32	2.1756014199048055e-35	0.9107260257905344	0.07384453993232289	0.0002946044227399	0.15600647217329466	206
hsa05017	Spinocerebellar ataxia	1	5.5459808951793984e-34	5.5459808951793984e-34	0.7421111801866596	0.17927062198333038	0.1041827330609496	0.19152348457599813	194
hsa05200	Pathways in cancer	1	6.031222128558327e-104	6.031222128558327e-104	0.7071256028324834	0.04809236200093491	3.574811529489293e-07	0.12484912597343553	202
hsa05206	MicroRNAs in cancer	1	1.788213905829335e-118	1.788213905829335e-118	0.8853805844729172	0.28865234799858386	0.2573605237769905	0.2571589886512888	172
hsa05170	Human immunodeficiency virus 1 infection	1	2.7107352959895914e-56	2.7107352959895914e-56	0.6832645663634462	0.061856697475950156	5.7451517766149524e-05	0.14189621419550844	198
hsa04060	Cytokine-cytokine receptor interaction	1	4.3899184129741656e-148	4.3899184129741656e-148	0.8257875977430509	0.1262700236171033	0.0011587236845111	0.212468084811378	189
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1	3.9972137112953445e-91	3.9972137112953445e-91	0.7309012366769446	0.07949282705093008	0.0002291563710864	0.16569439194191107	204
hsa04210	Apoptosis	1	2.307037174509865e-72	2.307037174509865e-72	0.52495405329796	0.06309867289226251	2.717759328027316e-05	0.12344233358089562	217
hsa05168	Herpes simplex virus 1 infection	1	1.5123268283482368e-72	1.5123268283482368e-72	0.8058692365915079	0.09027647506383334	6.818472009645092e-05	0.18331594902874274	195
hsa04071	Sphingolipid signaling pathway	4	3.0017006510129836e-30	6.362231497323479e-68	0.6083471684441114	0.07164481872706166	2.3490608204592084e-05	0.14650255696731937	210
hsa05166	Human T-cell leukemia virus 1 infection	1	4.3942662158775705e-78	4.3942662158775705e-78	0.9091665091230572	0.05091638413285848	1.8060325845156392e-05	0.1299983093778519	209
hsa05161	Hepatitis B	1	8.380446281694957e-79	8.380446281694957e-79	0.8143578253476781	0.06673216089597901	9.361596098771388e-07	0.1612992977126493	194
hsa05160	Hepatitis C	1	4.141056590166598e-43	4.141056590166598e-43	0.9075798300227028	0.11372637705745636	0.0014499293905101	0.21031105788038898	181
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1	6.177700908794106e-70	6.177700908794106e-70	0.6886172716262672	0.052433338684595876	1.2596778632539854e-06	0.13017942927272289	202
hsa05169	Epstein-Barr virus infection	2	1.317855368336544e-76	9.253840743029908e-79	0.816601102585833	0.05772780882069257	4.544663064044474e-07	0.1518133431552713	193
hsa05012	Parkinson disease	3	9.370810206638107e-27	1.1911052165802322e-41	0.8167710784795347	0.0901343704963918	0.0002597697826867	0.16512420006104905	241
hsa05014	Amyotrophic lateral sclerosis	2	2.2551011990583873e-49	7.767659624943839e-52	0.8760265166196192	0.12809158109074317	0.0256938248648005	0.18907322115710368	197
hsa05226	Gastric cancer	2	8.258117142891937e-46	2.046278449823593e-75	0.9107260257905344	0.07140443504032946	8.077953611475403e-06	0.15058099928006574	204
hsa05415	Diabetic cardiomyopathy	2	4.525498237662775e-37	5.414707903036127e-38	0.6138476861731054	0.052210176513497825	1.0508633645895914e-05	0.11544218608536586	232
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1	5.56013052940228e-45	5.56013052940228e-45	0.5971116875071725	0.05715561901265658	1.8220897142320025e-07	0.12887521364121451	201
hsa05203	Viral carcinogenesis	2	4.142610545089211e-65	2.2277064910808232e-70	0.6057067762937549	0.051387866184337716	7.461847352492488e-06	0.12817188862643164	207
hsa04979	Cholesterol metabolism	1	7.737044067263478e-72	7.737044067263478e-72	0.9041142434131516	0.45028032249505573	0.4984728808867296	0.3036348981183732	130
hsa05202	Transcriptional misregulation in cancer	1	1.185613241051572e-118	1.185613241051572e-118	0.6921124425837286	0.08258024107934725	0.00021110632002404998	0.16857965307186143	198
